Contact Us

For Marketing, Sales and Subscriptions Inquiries
2637 E Atlantic Blvd #43110
Pompano Beach, FL 33062
USA

Conference List

Genes Review

December 2015, Volume 1, 2, pp 33-36

A Review on the Use of Moxifloxacin in Multidrug Resistant Tuberculosis

Praveen. D

,

Priya Rajam Vivean.S

,

Shanmuga Priya.J

Praveen. D 1 ,

Priya Rajam Vivean.S 2
Shanmuga Priya.J 1 
  1. School of pharmaceutical sciences, Vels University, India 1

  2. chool of pharmaceutical sciences, Vels University, India 2

Pages: 33-36

DOI: 10.18488/journal.103/2015.1.2/103.2.33.36

Share :


Abstract:

The first line anti-tuberculosis drugs have shown an increasing prevalence of resistance. The higher incidence of TB has led to stronger requirements of other therapies apart from the World Health Organisation recommended Directly Observed Therapy in Short course (DOTS). New drugs highly effective against Mycobacterium tuberculosis (MTB) could enhance the treatment of cases with resistance to first line drugs (isoniazid and rifampicin) and may curtail the extent of present regular regimes. Fluoroquinolones are reasonably effective against Mycobacterium tuberculosis (MTB). They have been used as alternative for some present first-line drugs such as Isoniazid, and have been efficient even in Multi Drug Resistant Tuberculosis. These efforts must be further enhanced to ensure ultimate success in discovering, developing, and delivering drastically improved therapies for tuberculosis patients.
Contribution/ Originality
The paper’s primary contribution is finding that Moxifloxacin may curtail the time duration and adverse events in the case of multi drug resistant tuberculosis.

Keywords:


Video:

Reference:

  1. A. Garcia-Tapia, J. C. Rodriguez, M. Ruiz, and G. Royo, "Action of fluoroquinolones and linezolid on logarithmic- and stationary-phase culture of mycobacterium tuberculosis," Chemotherapy, vol. 50, pp. 211–213, 2004.
  2. P. Ball, "Safety profile of oral and intravenous moxifloxacin: Cumulative data from clinical trials and post marketing studies," Clinical Therapeutics, vol. 26, pp. 940–950, 2004.
  3. CDC, "Controlling tuberculosis in the United States: Recommendations from the American thoracic society, CDC, and the infectious diseases society of America," MMWR, vol. 54. Available www.cdc.gov/mmwr/preview/mmwrhtml/rr5412a1.htm, 2005.
  4. R. S. Dawe, S. H. Ibbotson, J. B. Sanderson, E. M. Thomson, and J. Ferguson, "A randomized controlled trial of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity," British Journal of Dermatology, vol. 149, pp. 1232–1241, 2003.
  5. J. C. Rodriguez, M. Ruiz, M. Lopez, and G. Royo, "In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against mycobacterium tuberculosis," International Journal Antimicrobial Agents, vol. 20, pp. 464–467, 2002.
  6. K. Tahaoglu and T. L. Torun, "The treatment of multidrug-resistant tuberculosis in Turkey," New England Journal of Medicine, vol. 345, pp. 170–174, 2001.
  7. A. Lubasch, R. Erbes, H. Mauch, and H. Lode, "Moxifloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy," European Respiratory Journal, vol. 17, pp. 641–646, 2001.
  8. W. W. Yew, C. K. Chan, and C. C. Leung, "Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: Preliminary results of a retrospective study from Hong Kong," Chest, vol. 124, pp. 1476–1481, 2003.
  9. R. D. Gosling, L. O. Uiso, N. E. Sam, E. Bongard, E. G. Kanduma, and M. Nyindo, "The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis," American Journal of Respiratory Critical Care Medicine, vol. 168, pp. 1342–1345, 2003.
  10. J. S. Mukherjee and M. L. Rich, "Programmes and principles in treatment of multi-drug resistant tuberculosis," Lancet, vol. 363, pp. 474–481, 2004.
  11. L. Richeldi and M. Covi, "Clinical use of levofloxacin in the long-term treatment of drug resistant tuberculosis," Archives of Chest Diseases, vol. 57, pp. 39–43, 2002.

Statistics:

Google Scholor ideas Microsoft Academic Search bing Google Scholor

Funding:

Competing Interests:

Acknowledgement:


Related Article

( 1 ) A Systematic Review to Explore the Scope of Global Interventions to Reduce the Incidence of Gastric Cancer
( 2 ) A Review of a Community Health Care Workers’ Programme in South Africa
( 3 ) Interventions for Reducing Coercion in Mental Health for Adults: A Systematic Review and the Impact of Updating
( 4 ) Prosthodontic Rehabilitatative Therapy through Surgical Obturator for Maxillectomy Patients: A Review
( 5 ) Review on Preparation and Description of Some First Series Divalent Transition Metal Complexes with Novel Schiff’s Base Ligands
( 6 ) The Social Context of Street Culture in Substance Use; a Literature Review of Homeless Youth Perspectives
( 7 ) Localized Amyloidosis of the Neck: A Rare Case and Literature Review
( 8 ) A Review on the Use of Moxifloxacin in Multidrug Resistant Tuberculosis
( 9 ) Pleural Effusion in Gorham-Stout Syndrome: A Case Report and a Literature Review
( 10 ) Stevia Derivative and its Potential Uses in Diabetic-Directed Foods. Review
( 11 ) Diagnosis of Childhood Apraxia of Speech: A Systematic Review
( 12 ) Oral Mucosal Lesions in Patient With Bullous Pemphigoid - A Rare Case and Literature Review
( 13 ) Access to HIV Prevention Services for Injecting Drug Users in Hai Phong, Vietnam: Qualitative Results
( 14 ) Cause, Magnitude and Contributing Factors for Maternal Death in Selected Hospitals in Snnpr between 2007/2008 and 2009/2010
( 15 ) Heart Failure in a Young Lady: A Reversible Cause
( 17 ) The Successful Treatment of Obstructive Uropathy Caused By Retroperitoneal Fibrosis with Steroids in the Latent Tuberculosis Case
( 19 ) Scedosporium Prolificans, An Unusual Cause of Frontal Abscess
( 21 ) Staff Nurses and Physicians Attitudes toward the Use of Electronic Patient Record
( 22 ) Ethnobotanic Study of Use of Medicinal Plants Utilized in the Quilombola Community of Chapada Da Natividade, Tocantins, Brazil